Figure 1

Receipt of selected therapies among ARIC community surveillance patients (1993-2002). (a) ACE inhibitors. (b) β-blockers. (c) Aspirin. (d) Optimal therapy. Model 1: nINC, Medicaid status, race, gender, age, study community, year of MI. Model 2: Model 1 plus hospital type (teaching vs. non-teaching), current or past history of hypertension, diabetes or heart failure, and presence of cardiac pain